Share this article and save a life!
The biggest healthcare supply chain innovation just dropped, and nobody’s talking about it.
Medline just became the first healthcare company to deploy AI robots that think, pick, and pack like humans.
On April 16, they partnered with Symbotic to revolutionize how medical supplies reach your hospital.
Think about this:
• Autonomous robots that know exactly what your OR needs before you do
• AI that maps every item to your hospital’s specific layout
• Zero human error in critical supply fulfillment
Why does this matter? 🎯
Remember the PPE crisis? The formula shortages? The IV fluid disasters?
Those weren’t just pandemic problems. They exposed a supply chain running on 1990s technology while treating 2026 patients.
Medline operates 45 distribution centers. They’re starting with one pilot in 2027.
But here’s what’s revolutionary: The AI doesn’t just move boxes. It learns consumption patterns, predicts demand spikes, and adapts to each hospital’s unique workflow.
Imagine your supply room knowing you’ll need extra surgical kits before your scheduler does.
This isn’t about replacing workers. It’s about ensuring that nurse hunting for gauze at 3 AM finds it instantly. That surgeon never runs out of the specific suture they prefer. That rural clinic gets the same speed and accuracy as downtown medical centers.
The healthcare industry spends $400 billion annually on supplies. We lose 25% to waste, expiration, and inefficiency.
Medline and Symbotic just declared war on that waste.
While everyone’s obsessed with clinical AI, the real revolution might be happening in the warehouse.
Because you can have the world’s best AI diagnostics, but if you can’t get basic supplies reliably, what’s the point?
♻️ Repost if healthcare supply chains need AI more than diagnostics
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
